ATS 2024 Final Program

Click on the session title to view the speakers

5

FRIDAY • MAY 17

2:25 Respiration Classification - Complex Patterns in Pulmonary Function 2:55 I’ll Huff and I’ll Puff: Expert Panel Case Debate 3:55 Concluding Remarks

8:50 COPD in Non-Smokers 9:05 Physiologic Impairment in COPD, Beyond FEV1 9:20 Questions and Answers 9:35 Break 10:05 Diagnosis of COPD: Reclassification Considerations 10:25 Informative Biomarkers in COPD: Are We There Yet? 10:45 Update on Radiologic Imaging in COPD 11:05 Revisiting COPD Exacerbations 11:25 Questions and Answers 11:40 Lunch 12:40 GOLD 2024 - What Is New? 1:00 Revisiting Inhaled Therapies for COPD 1:20 Biologics for COPD 1:40 Questions and Answers 1:55 Break 2:25 Advances in Bronchoscopic Approaches to COPD 2:40 Non-Invasive Ventilation in COPD 2:55 Telehealth and Home Pulmonary Rehabilitation 3:10 Inhaled Delivery Systems and Oxygen Therapy in COPD: Progress and Hurdles 3:25 Managing the Multimorbidity of COPD 3:40 Questions and Answers 3:55 Closing Remarks

CLINICAL POSTGRADUATE COURSE

PG6 COPD 2024: STATE OF THE ART R Pre-registration and additonal fees required. Attendance is limited. Member: $455 In-Training Member: $265 LMIC Member: $320 LMIC In-Training Member: $190 Non-Member: $560 In-Training Non-Member: $395 Assemblies on Clinical Problems; Allergy, Immunology and Inflammation; Pulmonary Rehabilitation; Respiratory Structure and Function 8:00 a.m. - 4:00 p.m. San Diego Convention Center Room 2 (Upper Level) Target Audience Clinicians, nurses, other allied health staff, researchers, investigators in basic and clinical pertinent to COPD, and sponsors of research Objectives At the conclusion of this session, the participant will be able to: • improve knowledge on COPD pathophysiology, clinical presentation, and assessment • gain competence in providing pharmacological and Non-pharmacological management to patients with COPD • recognize unmet needs for future research in the field This course will provide a state of the art update on the understanding of the pathophysiology, clinical course, assessment and management of COPD. It will shed light on recent and ongoing clinical trials and outline evidence-based pharmacological and non-pharmacological management strategies. Attendees will be updated on understanding COPD phenotypes, endotypes and biomarkers as well as recent advances in disease management. The course will also outline unmet and future research needs. 8:00 Welcome and Introduction

BASIC • CLINICAL • TRANSLATIONAL POSTGRADUATE COURSE

PG7 A PRIMER ON HEALTH EQUITY RESEARCH FOR CLINICAL, TRANSLATIONAL, AND BASIC SCIENTISTS R Pre-registration and additional fees required. Attendance is limited. Member: $455 In-Training Member: $265 LMIC Member: $320 LMIC In-Training Member: $190 Non-Member: $560 In-Training Non-Member: $395

8:05 Immunologic Underpinnings of COPD 8:20 Shedding Light on Genetics of COPD 8:35 Role of Microbiome in COPD

ATS 2024 Conference Program • San Diego, CA